Regulation of the Epigenome by Vitamin C

Annual Review of Nutrition

Volumn 35, Issue 1, 2015, Pages 545-564

  Young, Juan I ^a   Züchner, Stephan ^a   Wang, Gaofeng ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

DNA demethylation; Histone demethylation; Iron and 2 oxoglutarate dependent dioxygenase; JmjC domain containing histone demethylase; Ten eleven translocation dioxygenase; Vitamin C

Indexed keywords

ASCORBIC ACID; DIOXYGENASE; FERROUS ION; GAMMA BUTYROBETAINE DIOXYGENASE; HISTONE DEMETHYLASE; CYTOSINE;

DNA METHYLATION; EPIGENETICS; GENE CONTROL; HISTONE DEMETHYLATION; NEOPLASM; NUCLEAR REPROGRAMMING; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN DEPLETION; REVIEW; DRUG EFFECTS; GENETIC EPIGENESIS; HOMEOSTASIS; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION;

ASCORBIC ACID; CYTOSINE; DIOXYGENASES; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONE DEMETHYLASES; HOMEOSTASIS; HUMANS; OXIDATION-REDUCTION;

EID: 84937538653     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-071714-034228     Document Type: Review

References (93)

1. Babiarz J, Kane-Goldsmith N, Basak S, Liu K, YoungW, Grumet M. 2011. Juvenile and adult olfactory ensheathing cells bundle and myelinate dorsal root ganglion axons in culture. Exp. Neurol. 229:72-79
2. Blaschke K, Ebata KT, Karimi MM, Zepeda-Martinez JA, Goyal P, et al. 2013. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature 500:222-26
3. Brender JD, Werler MM, Kelley KE, Vuong AM, ShindeMU, et al., The National BirthDefects Prevention Study. 2011. Nitrosatable drug exposure during early pregnancy and neural tube defects in offspring: National Birth Defects Prevention Study. Am. J. Epidemiol. 174:1286-95
4. Brocato J, Costa M. 2014. 10th NTES Conference: Nickel and arsenic compounds alter the epigenome of peripheral blood mononuclear cells. J. Trace Elem. Med. Biol. doi: 10.1016/j.jtemb.2014.04.001
5. Bunge RP, Bunge MB, Eldridge CF. 1986. Linkage between axonal ensheathment and basal lamina production by Schwann cells. Annu. Rev. Neurosci. 9:305-28
6. Burns J, Ouvrier RA, Yiu EM, Joseph PD, Kornberg AJ, et al. 2009. Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial. Lancet Neurol. 8:537-44
7. Cameron E, Pauling L. 1976. Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer. PNAS 73:3685-89
8. Chen J, Guo L, Zhang L, Wu H, Yang J, et al. 2013. Vitamin C modulates Tet1 function during somatic cell reprogramming. Nat. Genet. 45:1504-9
9. Chen J, Liu H, Liu J, Qi J, Wei B, et al. 2013. H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat. Genet. 45:34-42
10. Chen ML, Shen F, Huang W, Qi JH, Wang Y, et al. 2013. Quantification of 5-methylcytosine and 5-hydroxymethylcytosine in genomic DNA from hepatocellular carcinoma tissues by capillary hydrophilicinteraction liquid chromatography/quadrupole time-of-flight mass spectrometry. Clin. Chem. 59:824-32
11. Chen Q, Gao S, HeW, Kou X, Zhao Y, et al. 2014. Xist repression shows time-dependent effects on the reprogramming of female somatic cells to induced pluripotent stem cells. Stem Cells 32:2642-56
12. ChungTL, Brena RM, Kolle G, Grimmond SM, Berman BP, et al. 2010. VitaminCpromotes widespread yet specific DNA demethylation of the epigenome in human embryonic stem cells. Stem Cells 28:1848-55
13. Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, et al. 2009. Mutation in TET2 in myeloid cancers. N. Engl. J. Med. 360:2289-301
14. Dickson KM, Gustafson CB, Young JI, Z uchner S, Wang G. 2013. Ascorbate-induced generation of 5-hydroxymethylcytosine is unaffected by varying levels of iron and 2-oxoglutarate. Biochem. Biophys. Res. Commun. 439:522-27
15. Doege CA, Inoue K, Yamashita T, Rhee DB, Travis S, et al. 2012. Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature 488:652-55
16. Eldridge CF, Bunge MB, Bunge RP, Wood PM. 1987. Differentiation of axon-related Schwann cells in vitro. I. Ascorbic acid regulates basal lamina assembly and myelin formation. J. Cell Biol. 105:1023-34
17. Erichsen HC, Engel SA, Eck PK, Welch R, Yeager M, et al. 2006. Genetic variation in the sodiumdependent vitamin C transporters, SLC23A1, and SLC23A2 and risk for preterm delivery. Am. J. Epidemiol. 163:245-54
18. Erichsen HC, Peters U, Eck P,Welch R, Schoen RE, et al. 2008. Genetic variation in sodium-dependent vitamin C transporters SLC23A1 and SLC23A2 and risk of advanced colorectal adenoma. Nutr. Cancer 60:652-59
19. Esteban MA, Wang T, Qin B, Yang J, Qin D, et al. 2010. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6:71-79
20. FigueroaME, Abdel-WahabO, LuC,Ward PS, Patel J, et al. 2010. Leukemic IDH1 and IDH2mutations result in a hypermethylation phenotype, disruptTET2function, and impair hematopoietic differentiation. Cancer Cell 18:553-67
21. M, Murta-Nascimento C, Lloreta J, Palencia L, et al., EPICURO/Spanish BladderCancer Study investigators. 2010. Genetic susceptibility to distinct bladder cancer subphenotypes. Eur. Urol. 57:283-92
22. Guo JU, Su Y, ZhongC,MingGL, Song H. 2011. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 145:423-34
23. Harbour JW, Roberson ED, Anbunathan H, Onken MD, Worley LA, Bowcock AM. 2013. Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. Nat. Genet. 45:133-35
24. Harris HR, Orsini N, Wolk A. 2014. Vitamin C and survival among women with breast cancer: a metaanalysis. Eur. J. Cancer 50:1223-31
25. He YF, Li BZ, Li Z, Liu P, Wang Y, et al. 2011. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333:1303-7
26. Hodges RE, Baker EM, Hood J, Sauberlich HE, March SC. 1969. Experimental scurvy in man. Am. J. Clin. Nutr. 22:535-48
27. Hood J. 1969. Femoral neuropathy in scurvy. N. Engl. J. Med. 281:1292-93
28. Hsu CH, Peng KL, Kang ML, Chen YR, Yang YC, et al. 2012. TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases. Cell Rep. 2:568-79
29. Inoue A, Zhang Y. 2011. Replication-dependent loss of 5-hydroxymethylcytosine in mouse preimplantation embryos. Science 334:194
30. Ito S, D Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. 2010. Role of TET dioxygenases in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466:1129-33
31. Ito S, Shen L, Dai Q, Wu SC, Collins LB, et al. 2011. TET dioxygenases can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333:1300-3
32. Jin SG, Jiang Y, Qiu R, Rauch TA, Wang Y, et al. 2011. 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res. 71:7360-65
33. Justin N, De Marco V, Aasland R, Gamblin SJ. 2010. Reading, writing and editing methylated lysines on histone tails: new insights from recent structural studies. Curr. Opin. Struct. Biol. 20:730-38
34. Karytinos A, Forneris F, Profumo A, Ciossani G, Battaglioli E, et al. 2009. A novel mammalian flavindependent histone demethylase. J. Biol. Chem. 284:17775-82
35. Klose RJ, Yamane K, Bae Y, Zhang D, Erdjument-Bromage H, et al. 2006. The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. Nature 442:312-16
36. Ko M, Huang Y, Jankowska AM, Pape UJ, Tahiliani M, et al. 2010. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 468:839-43
37. Koh KP, Yabuuchi A, Rao S, Huang Y, Cunniff K, et al. 2011. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 8:200-13
38. Kohli RM, Zhang Y. 2013. TET enzymes, TDG and the dynamics of DNA demethylation. Nature 502:472-79
39. Koshiishi I, Mamura Y, Liu J, Imanari T. 1998. Evaluation of an acidic deproteinization for the measurement of ascorbate and dehydroascorbate in plasma samples. Clin. Chem. 44:863-68
40. Kriaucionis S, Heintz N. 2009. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324:929-30
41. Kudo Y, Tateishi K, Yamamoto K, Yamamoto S, Asaoka Y, et al. 2012. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci. 103:670-76
42. Lane DJ, Chikhani S, Richardson V, Richardson DR. 2013. Transferrin iron uptake is stimulated by ascorbate via an intracellular reductive mechanism. Biochim. Biophys. Acta 1833:1527-41
43. Lane DJ, Lawen A. 2008. Non-transferrin iron reduction and uptake are regulated by transmembrane ascorbate cycling in K562 cells. J. Biol. Chem. 283:12701-8
44. Lane DJ, Robinson SR, Czerwinska H, Bishop GM, Lawen A. 2010. Two routes of iron accumulation in astrocytes: ascorbate-dependent ferrous iron uptake via the divalent metal transporter (DMT1) plus an independent route for ferric iron. Biochem. J. 432:123-32
45. Lian CG, Xu Y, Ceol C,Wu F, Larson A, et al. 2012. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 150:1135-46
46. Linster CL, Van Schaftingen E. 2007. Vitamin C. Biosynthesis, recycling and degradation in mammals. FEBS J. 274:1-22
47. Lorsbach RB, Moore J, Mathew S, Raimondi SC, Mukatira ST, Downing JR. 2003. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia 17:637-41
48. Luo J, Shen L, Zheng D. 2014. Association between vitamin C intake and lung cancer: a dose-response meta-analysis. Sci. Rep. 4:6161
49. Maiti A, Drohat AC. 2011. Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation ofCpGsites. J. Biol.Chem. 286:35334-38
50. Mandl J, Szarka A, Banhegyi G. 2009. Vitamin C: update on physiology and pharmacology. Br. J. Pharmacol. 157:1097-110
51. Manning J, Mitchell B, Appadurai DA, Shakya A, Pierce LJ, et al. 2013. Vitamin C promotes maturation of T-cells. Antioxid. Redox Signal. 19:2054-67
52. Mashima Y, Kigasawa K,Wakakura M, Oguchi Y. 2000. Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy? J. Neuroophthalmol. 20:166-70
53. Mason EF, Hornick JL. 2013. Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis. Mod. Pathol. 26:1492-97
54. May JM. 2011. The SLC23 family of ascorbate transporters: ensuring that you get and keep your daily dose of vitamin C. Br. J. Pharmacol. 164:1793-801
55. McDonough MA, Loenarz C, Chowdhury R, Clifton IJ, Schofield CJ. 2010. Structural studies on human 2-oxoglutarate dependent oxygenases. Curr. Opin. Struct. Biol. 20:659-72
56. McGarvey ML, Baron-Van Evercooren A, Kleinman HK, Dubois-Dalcq M. 1984. Synthesis and effects of basement membrane components in cultured rat Schwann cells. Dev. Biol. 105:18-28
57. Michels AJ, JoisherN,Hagen TM. 2003. Age-related decline of sodium-dependent ascorbic acid transport in isolated rat hepatocytes. Arch. Biochem. Biophys. 410:112-20
58. Minor EM, Court BL, Young JI, Wang G. 2013. Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine. J. Biol. Chem. 288:13669-74
59. Monfort A,Wutz A. 2013. Breathing-in epigenetic change with vitamin C. EMBO Rep. 14:337-46
60. Mosammaparast N, Shi Y. 2010. Reversal of histone methylation: biochemical andmolecular mechanisms of histone demethylases. Annu. Rev. Biochem. 79:155-79
61. M uller T, Gessi M, Waha A, Isselstein LJ, Luxen D, et al. 2012. Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas. Am. J. Pathol. 181:675-83
62. Olsen CL, Bunge RP. 1986. Requisites for growth and myelination of urodele sensory neurons in tissue culture. J. Exp. Zool. 238:373-84
63. Orr BA, Haffner MC, Nelson WG, Yegnasubramanian S, Eberhart CG. 2012. Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. PLOS ONE 7:e41036
64. Pareyson D, Reilly MM, Schenone A, Fabrizi GM, Cavallaro T, et al., CMT-TRIAAL, CMT-TRAUK groups. 2011. Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMTTRAUK): a double-blind randomised trial. Lancet Neurol. 10:320-28
65. Passage E, Norreel JC,Noack-Fraissignes P, Sanguedolce V, Pizant J, et al. 2004. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat. Med. 10:396-401
66. PennNW,Suwalski R, O RileyC, BojanowskiK,YuraR. 1972. The presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid. Biochem. J. 126:781-90
67. Perez C, Martinez-Calle N, Martin-Subero JI, Segura V, Delabesse E, et al. 2012. TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia. PLOS ONE 7:e31605
68. QuesadaV,Conde L, Villamor N, OrdonezGR, JaresP, et al. 2011. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat. Genet. 44:47-52
69. Rice ME, Russo-Menna I. 1998. Differential compartmentalization of brain ascorbate and glutathione between neurons and glia. Neuroscience 82:1213-23
70. RossorAM, Polke JM, HouldenH,ReillyMM.2013. Clinical implications of genetic advances inCharcot-Marie-Tooth disease. Nat. Rev. Neurol. 9:562-71
71. Rothbart SB, Strahl BD. 2014. Interpreting the language of histone and DNA modifications. Biochim. Biophys. Acta 1839:627-43
72. Schleicher RL, Carroll MD, Ford ES, Lacher DA. 2009. Serum vitamin C and the prevalence of vitamin C deficiency in the United States: 2003-2004 National Health and Nutrition Examination Survey (NHANES). Am. J. Clin. Nutr. 90:1252-63
73. Schorah CJ, Wild J, Hartley R, Sheppard S, Smithells RW. 1983. The effect of periconceptional supplementation on blood vitamin concentrations in women at recurrence risk for neural tube defect. Br. J. Nutr. 49:203-11
74. Shen L, Zhang Y. 2013. 5-Hydroxymethylcytosine: generation, fate, and genomic distribution. Curr. Opin. Cell Biol. 25:289-96
75. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, et al. 2004. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119:941-53
76. Shi YG, Tsukada Y. 2013. The discovery of histone demethylases. Cold Spring Harb. Perspect. Biol. 5:a017947
77. Simpson GL, Ortwerth BJ. 2000. The non-oxidative degradation of ascorbic acid at physiological conditions. Biochim. Biophys. Acta 1501:12-24
78. Skibola CF, Bracci PM, Halperin E, Nieters A, Hubbard A, et al. 2008. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma. PLOS ONE 3:e2816
79. Spielholz C, Golde DW, Houghton AN, Nualart F, Vera JC. 1997. Increased facilitated transport of dehydroascorbic acid without changes in sodium-dependent ascorbate transport in human melanoma cells. Cancer Res. 57:2529-37
80. Stadtfeld M, Apostolou E, Ferrari F, Choi J, Walsh RM, et al. 2012. Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells. Nat. Genet. 44:398-405
81. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, et al. 2009. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324:930-35
82. Tan L, Shi YG. 2012. Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development 139:1895-902
83. Timpson NJ, Forouhi NG, Brion MJ, Harbord RM, Cook DG, et al. 2010. Genetic variation at the SLC23A1 locus is associated with circulating concentrations of L-ascorbic acid (vitamin C): evidence from 5 independent studies with 15,000 participants. Am. J. Clin. Nutr. 92:375-82
84. TsukadaY, Fang J,Erdjument-Bromage H, WarrenME, BorchersCH,et al. 2006. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439:811-16
85. Wang L, Zhang J, Duan J, Gao X, Zhu W, et al. 2014. Programming and inheritance of parental DNA methylomes in mammals. Cell 157:979-91
86. Wang T, Chen K, Zeng X, Yang J, Wu Y, et al. 2011. The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. Cell Stem Cell 9:575-87
87. Wilson JX. 2005. Regulation of vitamin C transport. Annu. Rev. Nutr. 25:105-25
88. Wright ME, Andreotti G, Lissowska J, Yeager M, Zatonski W, et al. 2009. Genetic variation in sodiumdependent ascorbic acid transporters and risk of gastric cancer in Poland. Eur. J. Cancer 45:1824-30
89. Wyatt GR,Cohen SS. 1952. A new pyrimidine base from bacteriophage nucleic acids. Nature 170:1072-73
90. Xu W, Yang H, Liu Y, Yang Y,Wang P, et al. 2011. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell 19:17-30
91. Yang H, Liu Y, Bai F, Zhang JY, Ma SH, et al. 2013. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 32:663-69
92. Yin R, Mao SQ, Zhao B, Chong Z, Yang Y, et al. 2013. Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals. J. Am. Chem. Soc. 135:10396-403
93. Yulin X, Lizhen L, Lifei Z, Shan F, Ru L, et al. 2012. Efficient generation of induced pluripotent stem cells from human bone marrow mesenchymal stem cells. Folia Biol. (Praha) 58:221-23